ArticleRSC advances2020

Highly-controllable drug release from core cross-linked singlet oxygen-responsive nanoparticles for cancer therapy.

Jiayan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.